Table 5: Treatment outcomes of some similar studies

Study N (Ages) Regimen CR EFS OS
Coiffier B, et al 202 (60 – 80) RCHOP 75% 2 years – 57% 10 years – 36% 2 years – 75% 10 years – 43%
Habermann, et al 267 (> 60) RCHOP 77% 3 years – 53% 3 years – 67%
Pfreundschuh, et al 1222 (61 – 80) RCHOP 78% 3 years – 66% 3 years – 78%
Spina, et al 100 (70 – 89) RCHOP 83% 5 years – 67% 5 years – 54%
Olivieri, et al 74 (65 – 92) RCHOP 81% 5 years – 31% 5 years – 46%
Merli, et al 224 (64 – 86) RCHOP 73% 5 years – 48% 5 years – 62%
Le Thanh Tu 69 (> 60) RCHOP 84% 5 years – 55% 5 years – 69%
Our study 21 (60-80) RCHOP or RCVP 76.2% 26 months – 60% 26 months – 75%